Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
16 p, 1.7 MB Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries / Pisana, Alice (Karolinska Institutet (Estocolm, Suècia)) ; Wettermark, Björn (Vilnius University) ; Kurdi, Amanj (Sefako Makgatho Health Sciences University) ; Tubic, Biljana (University of Banja Luka) ; Pontes García, Caridad (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Zara, Corinne (Servei Català de la Salut) ; Van Ganse, Eric (Croix Rousse University Hospital (Lyon, França)) ; Petrova, Guenka (PharmacoEpidemiology Lyon) ; Mardare, Ileana ("Carol Davila" University of Medicine and Pharmacy) ; Fürst, Jurij (Health Insurance Institute) ; Roig-Izquierdo, Marta (Servei Català de la Salut) ; Melien, Oyvind (Oslo University Hospital (Oslo, Noruega)) ; Bonanno, Patricia Vella (University of Malta) ; Banzi, Rita (Istituto di Ricerche Farmacologiche Mario Negri IRCCS) ; Marković-Peković, Vanda (University of Banja Luka) ; Mitkova, Zornitsa (PharmacoEpidemiology Lyon) ; Godman, Brian (Ajman University)
Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluation generates uncertainty over their cost-effectiveness and increases expenditure for unknown health gain. [...]
2022 - 10.3389/fphar.2022.873556
Frontiers in Pharmacology, Vol. 13 (june 2022)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.